196 related articles for article (PubMed ID: 26855319)
21. Altered N-Glycan expression profile in epithelial-to-mesenchymal transition of NMuMG cells revealed by an integrated strategy using mass spectrometry and glycogene and lectin microarray analysis.
Tan Z; Lu W; Li X; Yang G; Guo J; Yu H; Li Z; Guan F
J Proteome Res; 2014 Jun; 13(6):2783-95. PubMed ID: 24724545
[TBL] [Abstract][Full Text] [Related]
22. O-linked mucin-type glycosylation in breast cancer.
Burchell JM; Beatson R; Graham R; Taylor-Papadimitriou J; Tajadura-Ortega V
Biochem Soc Trans; 2018 Aug; 46(4):779-788. PubMed ID: 29903935
[TBL] [Abstract][Full Text] [Related]
23. Cell surface glycan-lectin interactions in tumor metastasis.
Rambaruth ND; Dwek MV
Acta Histochem; 2011 Oct; 113(6):591-600. PubMed ID: 21501858
[TBL] [Abstract][Full Text] [Related]
24. Galectin-Binding O-Glycosylations as Regulators of Malignancy.
Dimitroff CJ
Cancer Res; 2015 Aug; 75(16):3195-202. PubMed ID: 26224120
[TBL] [Abstract][Full Text] [Related]
25. Tumor suppressor p16INK4a--modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells.
André S; Sanchez-Ruderisch H; Nakagawa H; Buchholz M; Kopitz J; Forberich P; Kemmner W; Böck C; Deguchi K; Detjen KM; Wiedenmann B; von Knebel Doeberitz M; Gress TM; Nishimura S; Rosewicz S; Gabius HJ
FEBS J; 2007 Jul; 274(13):3233-56. PubMed ID: 17535296
[TBL] [Abstract][Full Text] [Related]
26. Glycoengineering of Chinese hamster ovary cells for enhanced erythropoietin N-glycan branching and sialylation.
Yin B; Gao Y; Chung CY; Yang S; Blake E; Stuczynski MC; Tang J; Kildegaard HF; Andersen MR; Zhang H; Betenbaugh MJ
Biotechnol Bioeng; 2015 Nov; 112(11):2343-51. PubMed ID: 26154505
[TBL] [Abstract][Full Text] [Related]
27. Glycobiology of Eosinophilic Inflammation: Contributions of Siglecs, Glycans, and Other Glycan-Binding Proteins.
O'Sullivan JA; Carroll DJ; Bochner BS
Front Med (Lausanne); 2017; 4():116. PubMed ID: 28824909
[TBL] [Abstract][Full Text] [Related]
28. Identifying Genetic Regulators of Protein-Glycan Interactions with Genome-Wide CRISPR Screening.
Krishnamoorthy V; Daly J; Wisnovsky S
Curr Protoc; 2023 Jan; 3(1):e646. PubMed ID: 36695498
[TBL] [Abstract][Full Text] [Related]
29. Assembly, organization and regulation of cell-surface receptors by lectin-glycan complexes.
Elola MT; Blidner AG; Ferragut F; Bracalente C; Rabinovich GA
Biochem J; 2015 Jul; 469(1):1-16. PubMed ID: 26173257
[TBL] [Abstract][Full Text] [Related]
30. Glyconanotechnology.
Reichardt NC; Martín-Lomas M; Penadés S
Chem Soc Rev; 2013 May; 42(10):4358-76. PubMed ID: 23303404
[TBL] [Abstract][Full Text] [Related]
31. Altered tumor-cell glycosylation promotes metastasis.
Häuselmann I; Borsig L
Front Oncol; 2014; 4():28. PubMed ID: 24592356
[TBL] [Abstract][Full Text] [Related]
32. I-branched carbohydrates as emerging effectors of malignant progression.
Dimitroff CJ
Proc Natl Acad Sci U S A; 2019 Jul; 116(28):13729-13737. PubMed ID: 31213534
[TBL] [Abstract][Full Text] [Related]
33. Glycobiology Modifications in Intratumoral Hypoxia: The Breathless Side of Glycans Interaction.
Silva-Filho AF; Sena WLB; Lima LRA; Carvalho LVN; Pereira MC; Santos LGS; Santos RVC; Tavares LB; Pitta MGR; Rêgo MJBM
Cell Physiol Biochem; 2017; 41(5):1801-1829. PubMed ID: 28376491
[TBL] [Abstract][Full Text] [Related]
34. Complex N-glycans are the major ligands for galectin-1, -3, and -8 on Chinese hamster ovary cells.
Patnaik SK; Potvin B; Carlsson S; Sturm D; Leffler H; Stanley P
Glycobiology; 2006 Apr; 16(4):305-17. PubMed ID: 16319083
[TBL] [Abstract][Full Text] [Related]
35. Lectin-epithelial interactions in the human colon.
Rhodes JM; Campbell BJ; Yu LG
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1482-6. PubMed ID: 19021580
[TBL] [Abstract][Full Text] [Related]
36. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
[TBL] [Abstract][Full Text] [Related]
37. Quantitative glycome analysis of N-glycan patterns in bladder cancer vs normal bladder cells using an integrated strategy.
Yang G; Tan Z; Lu W; Guo J; Yu H; Yu J; Sun C; Qi X; Li Z; Guan F
J Proteome Res; 2015 Feb; 14(2):639-53. PubMed ID: 25536294
[TBL] [Abstract][Full Text] [Related]
38. Canvassing Prospects of Glyco-Nanovaccines for Developing Cross-Presentation Mediated Anti-Tumor Immunotherapy.
Makandar AI; Jain M; Yuba E; Sethi G; Gupta RK
Vaccines (Basel); 2022 Nov; 10(12):. PubMed ID: 36560459
[TBL] [Abstract][Full Text] [Related]
39. Targeting the "Sweet Side" of Tumor with Glycan-Binding Molecules Conjugated-Nanoparticles: Implications in Cancer Therapy and Diagnosis.
Bloise N; Okkeh M; Restivo E; Della Pina C; Visai L
Nanomaterials (Basel); 2021 Jan; 11(2):. PubMed ID: 33499388
[TBL] [Abstract][Full Text] [Related]
40. Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer.
Rabinovich GA; Croci DO
Immunity; 2012 Mar; 36(3):322-35. PubMed ID: 22444630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
